Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Recruiting 12Completed 7Not yet recruiting 6Terminated 5Unknown 3Enrolling by invitation 1Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 2Sarcoma 1

Conditions

Osteosarcoma 1NSCLC 1Advanced Squamous Non-Small-Cell Lung Cancer 1

Interventions

Cisplatin 509Cyclophosphamide 360Carboplatin 352Radiotherapy 350Capecitabine 329Paclitaxel 325Oxaliplatin 324Gemcitabine 319Docetaxel 311Fluorouracil 283Drug Therapy 243apatinib 242Bevacizumab 229camrelizumab 214Etoposide 200Irinotecan 176Doxorubicin 175Leucovorin 161Dexamethasone 160sintilimab 142pembrolizumab 138anlotinib 136Pemetrexed 136Cytarabine 136toripalimab 129Neoadjuvant Therapy 122S 1 (combination) 120Vincristine 119Rituximab 117Radiosurgery 117

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unknown × Interventional × trilaciclib × Clear all
NCT06328049 2024-03-25

A Study of Trilaciclib Combined With Chemotherapy in the Treatment of NSCLC

Taixing People's Hospital

Phase 2 Unknown
30 enrolled
Thoracic

NSCLC

NCT06217003 2024-01-22

Trilaciclib Combined With Chemotherapy for Perioperative Treatment of Osteosarcoma

The First Affiliated Hospital of Xinxiang Medical College

Phase 2 Unknown
20 enrolled
Sarcoma

Osteosarcoma

NCT05900921 2023-06-13

Trilaciclib Prior to Chemotherapy Plus Tislelizumab as 1L Treatment for Advanced Squamous Non-Small-Cell Lung Cancer

Sichuan University

Phase 2 Unknown
132 enrolled
Thoracic

Advanced Squamous Non-Small-Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡